ITC Votes to Institute Patent Case on Q10 "Anti-Aging" Products, Etc.
The International Trade Commission has voted to institute a section 337 patent-based investigation of certain coenzyme Q10 products and method of making same (used in "heart healthy" nutritional supplements and in "anti-aging" cosmetics), pursuant to a complaint filed by Kaneka…
Sign up for a free preview to unlock the rest of this article
Communications Daily is required reading for senior executives at top telecom corporations, law firms, lobbying organizations, associations and government agencies (including the FCC). Join them today!
Corporation of Japan against Zhejiang Medicine Co., Ltd.; ZMC-USA, LLC; Xiamen Kingdomway Group Company; Pacific Rainbow International, Inc.; Mitsubishi Gas Chemical Company, Inc.; Maypro Industries, Inc.; and Shenzhou Biology & Technology Co., Ltd. (Inv. No. 337-TA-790). (See ITT's Online Archives or 06/22/11 news, 11062238, for BP summary of ITC receiving this patent complaint.)